Medicine recalls
|
| |
| Batch Recall of Honpo Seirogan Pills |
| |
The Department of Health (DH) today (May 2) endorsed a licensed drug wholesaler, namely Leepharm Enterprises Limited (Leepharm), to recall two batches (batch number: BAA9 and JAA9) of Honpo Seirogan Pills (HK-54060) manufactured by a Japan manufacturer, Kyokuto Co. Ltd. (Kyokuto) from the market due to potential quality issue.
The DH received notification from overseas authority on suspension of operations of Kyokuto in pharmaceutical manufacturing and sales business, Kyokuto conducted voluntary recalls for products that were thought to have an impact on quality. In the notification, it was reported that there was no risk of serious health damage caused by the product and there have been no reports of health damage related to the incident. According to available information and after impact assessment, as a precautionary measure, Leepharm is voluntarily recalling the above batches from the market.
The above product, containing creosote, Phellodendron bark, Sophora root and Citrus unshiu peel, is an over-the-counter medicine indicated for relief of occasional diarrhea. According to Leepharm, the above two batches of product have only been imported into Hong Kong in 2019 and supplied to local pharmacies, medicine stores and re-exported to Macau.
Leepharm has set up a hotline (2815 1525) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above batches of product. The DH will closely monitor the recall.
Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product.
Ends/Thursday, May 2, 2024
|
| |
|
